ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 000589

Monoamine oxidase-B inhibition in Alzheimer's disease

Identifieur interne : 000589 ( PascalFrancis/Curation ); précédent : 000588; suivant : 000590

Monoamine oxidase-B inhibition in Alzheimer's disease

Auteurs : Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne]

Source :

Neurotoxicology : (Park Forest South) [ 0161-813X ] ; 2004.

RBID : Pascal:04-0191604

Descripteurs français

Pascal (Inist)
- Amine oxidase (flavin-containing), Inhibition, Inhibiteur, Démence Alzheimer, Neurologie, Toxicologie.
Wicri :
- topic : Neurologie, Toxicologie.

English descriptors

KwdEn :
- Alzheimer disease, Amine oxidase (flavin-containing), Inhibition, Inhibitor, Neurology, Toxicology.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in late life. There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both. There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources. The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span. This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.

A01	`01`	`1`		`@0 0161-813X`
A03		`1`		`@0 Neurotoxicology : (Park Forest South)`
A05				`@2 25`
A06				`@2 1-2`
A08	`01`	`1`	`ENG`	`@1 Monoamine oxidase-B inhibition in Alzheimer's disease`
A09	`01`	`1`	`ENG`	`@1 Monoamine Oxidases: Molecular, Pharmacological and Neurotoxicological Aspects. A Tribute to Prof. Merton Sandler`
A11	`01`	`1`		`@1 RIEDERER (Peter)`
A11	`02`	`1`		`@1 DANIELCZYK (Walter)`
A11	`03`	`1`		`@1 GRÜNBLATT (Edna)`
A12	`01`	`1`		`@1 NICOTRA (A.) @9 ed.`
A12	`02`	`1`		`@1 PARVEZ (S. H.) @9 ed.`
A12	`03`	`1`		`@1 GLOVER (V.) @9 ed.`
A12	`04`	`1`		`@1 SANDLER (M.) @9 ed.`
A12	`05`	`1`		`@1 PARVEZ (S.) @9 ed.`
A12	`06`	`1`		`@1 MINAMI (M.) @9 ed.`
A14	`01`			`@1 Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15 @2 97080 Würzburg @3 DEU @Z 1 aut. @Z 3 aut.`
A14	`02`			`@1 Ludwig Boltzmann Institute of Clinical Neurobiology @2 Vienna @3 AUT @Z 2 aut.`
A15	`01`			`@1 Dept. Animal and Human Biology, University of Rome I, Viale dell'Università 32 @2 00198 Rome @3 ITA @Z 1 aut.`
A15	`02`			`@1 Institut Alfred Fressard of Neuroscience, Bât5 Parc Chateau, CNRS @2 91190 Gif sur Yvette @3 FRA @Z 2 aut. @Z 5 aut.`
A15	`03`			`@1 Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Campus, Du Cane Road @2 London, W12 ONN @3 GBR @Z 3 aut. @Z 4 aut.`
A15	`04`			`@1 The Research Institute of Personalized Health, Health Sciences University of Hokkaido @2 061-0293 Ishikari-Tobetsu @3 JPN @Z 6 aut.`
A20				`@1 271-277`
A21				`@1 2004`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 18397 @5 354000119285470280`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 2 p.1/2`
A47	`01`	`1`		`@0 04-0191604`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Neurotoxicology : (Park Forest South)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Alzheimer's disease (AD) is the most common cause of dementia in late life. There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both. There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources. The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span. This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.
C02	`01`	`X`		`@0 002A25`
C02	`02`	`X`		`@0 002B03`
C02	`03`	`X`		`@0 002B17`
C03	`01`	`X`	`FRE`	`@0 Amine oxidase (flavin-containing) @2 FE @5 01`
C03	`01`	`X`	`ENG`	`@0 Amine oxidase (flavin-containing) @2 FE @5 01`
C03	`01`	`X`	`SPA`	`@0 Amine oxidase (flavin-containing) @2 FE @5 01`
C03	`02`	`X`	`FRE`	`@0 Inhibition @5 04`
C03	`02`	`X`	`ENG`	`@0 Inhibition @5 04`
C03	`02`	`X`	`SPA`	`@0 Inhibición @5 04`
C03	`03`	`X`	`FRE`	`@0 Inhibiteur @5 07`
C03	`03`	`X`	`ENG`	`@0 Inhibitor @5 07`
C03	`03`	`X`	`SPA`	`@0 Inhibidor @5 07`
C03	`04`	`X`	`FRE`	`@0 Démence Alzheimer @5 11`
C03	`04`	`X`	`ENG`	`@0 Alzheimer disease @5 11`
C03	`04`	`X`	`SPA`	`@0 Demencia Alzheimer @5 11`
C03	`05`	`X`	`FRE`	`@0 Neurologie @5 12`
C03	`05`	`X`	`ENG`	`@0 Neurology @5 12`
C03	`05`	`X`	`SPA`	`@0 Neurología @5 12`
C03	`06`	`X`	`FRE`	`@0 Toxicologie @5 14`
C03	`06`	`X`	`ENG`	`@0 Toxicology @5 14`
C03	`06`	`X`	`SPA`	`@0 Toxicología @5 14`
C07	`01`	`X`	`FRE`	`@0 Oxidoreductases @2 FE`
C07	`01`	`X`	`ENG`	`@0 Oxidoreductases @2 FE`
C07	`01`	`X`	`SPA`	`@0 Oxidoreductases @2 FE`
C07	`02`	`X`	`FRE`	`@0 Enzyme @2 FE`
C07	`02`	`X`	`ENG`	`@0 Enzyme @2 FE`
C07	`02`	`X`	`SPA`	`@0 Enzima @2 FE`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 61`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 61`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 61`
C07	`04`	`X`	`FRE`	`@0 Maladie dégénérative @5 62`
C07	`04`	`X`	`ENG`	`@0 Degenerative disease @5 62`
C07	`04`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 62`
C07	`05`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 63`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 63`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 63`
C07	`06`	`X`	`FRE`	`@0 Système nerveux pathologie @5 64`
C07	`06`	`X`	`ENG`	`@0 Nervous system diseases @5 64`
C07	`06`	`X`	`SPA`	`@0 Sistema nervioso patología @5 64`
N21				`@1 131`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E45

Links to Exploration step

Pascal:04-0191604

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Monoamine oxidase-B inhibition in Alzheimer's disease</title>
<author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15</s1>
<s2>97080 Würzburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Danielczyk, Walter" sort="Danielczyk, Walter" uniqKey="Danielczyk W" first="Walter" last="Danielczyk">Walter Danielczyk</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Grunblatt, Edna" sort="Grunblatt, Edna" uniqKey="Grunblatt E" first="Edna" last="Grünblatt">Edna Grünblatt</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15</s1>
<s2>97080 Würzburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0191604</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0191604 INIST</idno>
<idno type="RBID">Pascal:04-0191604</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E45</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000589</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Monoamine oxidase-B inhibition in Alzheimer's disease</title>
<author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15</s1>
<s2>97080 Würzburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Danielczyk, Walter" sort="Danielczyk, Walter" uniqKey="Danielczyk W" first="Walter" last="Danielczyk">Walter Danielczyk</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Grunblatt, Edna" sort="Grunblatt, Edna" uniqKey="Grunblatt E" first="Edna" last="Grünblatt">Edna Grünblatt</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15</s1>
<s2>97080 Würzburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer disease</term>
<term>Amine oxidase (flavin-containing)</term>
<term>Inhibition</term>
<term>Inhibitor</term>
<term>Neurology</term>
<term>Toxicology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Amine oxidase (flavin-containing)</term>
<term>Inhibition</term>
<term>Inhibiteur</term>
<term>Démence Alzheimer</term>
<term>Neurologie</term>
<term>Toxicologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Neurologie</term>
<term>Toxicologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Alzheimer's disease (AD) is the most common cause of dementia in late life. There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both. There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources. The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span. This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0161-813X</s0>
</fA01>
<fA03 i2="1"><s0>Neurotoxicology : (Park Forest South)</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>1-2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Monoamine oxidase-B inhibition in Alzheimer's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Monoamine Oxidases: Molecular, Pharmacological and Neurotoxicological Aspects. A Tribute to Prof. Merton Sandler</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>RIEDERER (Peter)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DANIELCZYK (Walter)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GRÜNBLATT (Edna)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>NICOTRA (A.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>PARVEZ (S. H.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>GLOVER (V.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>SANDLER (M.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1"><s1>PARVEZ (S.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="06" i2="1"><s1>MINAMI (M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Neurochemical Laboratory, Clinic for Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstr. 15</s1>
<s2>97080 Würzburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Dept. Animal and Human Biology, University of Rome I, Viale dell'Università 32</s1>
<s2>00198 Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Institut Alfred Fressard of Neuroscience, Bât5 Parc Chateau, CNRS</s1>
<s2>91190 Gif sur Yvette</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Campus, Du Cane Road</s1>
<s2>London, W12 ONN</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA15>
<fA15 i1="04"><s1>The Research Institute of Personalized Health, Health Sciences University of Hokkaido</s1>
<s2>061-0293 Ishikari-Tobetsu</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</fA15>
<fA20><s1>271-277</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18397</s2>
<s5>354000119285470280</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>2 p.1/2</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0191604</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Neurotoxicology : (Park Forest South)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Alzheimer's disease (AD) is the most common cause of dementia in late life. There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both. There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources. The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span. This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A25</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B03</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Amine oxidase (flavin-containing)</s0>
<s2>FE</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Amine oxidase (flavin-containing)</s0>
<s2>FE</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Amine oxidase (flavin-containing)</s0>
<s2>FE</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Inhibition</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Inhibition</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Inhibición</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Inhibiteur</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Inhibitor</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Inhibidor</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Démence Alzheimer</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Alzheimer disease</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Demencia Alzheimer</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Neurologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Neurology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Neurología</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Toxicologie</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Toxicology</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Toxicología</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>64</s5>
</fC07>
<fN21><s1>131</s1>
</fN21>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000589 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000589 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0191604
   |texte=   Monoamine oxidase-B inhibition in Alzheimer's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Monoamine oxidase-B inhibition in Alzheimer's disease

Monoamine oxidase-B inhibition in Alzheimer's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri